{"id":260859,"date":"2023-11-07T07:14:00","date_gmt":"2023-11-07T07:14:00","guid":{"rendered":"https:\/\/sola-diagnostics.com\/?p=260859"},"modified":"2025-01-09T11:57:09","modified_gmt":"2025-01-09T10:57:09","slug":"90-less-surgical-diagnostic-procedures-with-the-wid-easy-test","status":"publish","type":"post","link":"https:\/\/sola-diagnostics.com\/en\/90-less-surgical-diagnostic-procedures-with-the-wid-easy-test\/","title":{"rendered":"90 % less surgical diagnostic procedures with the WID\u00ae-easy Test"},"content":{"rendered":"

[et_pb_section fb_built=”1″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

A recent study published in T H E L A N C E T O n c o l o g y demonstrated the ability of the new WID\u00ae-easy Test to render 90% of surgical diagnostic procedures, e.g., hysteroscopy and curettage, unnecessary in women with abnormal bleeding during or after menopause.<\/strong><\/p>\n

The test speeds up the diagnosis of women with suspected uterine cancers, leading to less radical surgery, less need for radio- and chemotherapy, better chances of cure and healthcare cost savings.<\/strong><\/p>\n

Download<\/a> the paper here<\/a>.<\/strong><\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

In 400 women aged 45 and over who visited UCL-Hospital in London because of abnormal bleeding, the standard procedure for uterine cancer diagnosis included a series of imaging procedures (mainly sonography) followed, if necessary, by diagnostic surgery (hysteroscopy and curettage). The prospective study was conducted to compare the performance of the the WID\u00ae-easy Test with sonography.<\/p>\n

Both sonography and the new WID\u00ae-easy Test (\u201cWID\u00ae-qEC test\u201d in the scientific literature) correctly detected the same number of uterine cancer cases (91\u00a0%). However, the WID\u00ae-easy Test reduces the number of women who need surgical diagnostic procedures such as hysteroscopy and curettage, even though they do not have cancer, by 87% compared to the standard procedure in the UK and by 95% compared to the standard procedure in Germany, Switzerland and Austria.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”Imaging vs WID\u00ae-easy” image=”https:\/\/sola-diagnostics.com\/wp-content\/uploads\/2024\/07\/image-2.png” _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

\n
This simplified graphic illustrates the 95% reduction in false positive results with the new WID\u00ae-easy Test compared to the current standard method, sonography.<\/figcaption><\/figure>\n<\/div>\n

 <\/p>\n

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

The WID\u00ae-easy Test speeds diagnosis in women with symptoms of endometrial cancer, leading to better outcomes and healthcare cost savings.<\/p>\n

WID\u00ae-easy is an epigenetic test examining two DNA regions showing increased DNA methylation in women with uterine cancer.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_blurb title=”The WID\u00ae-easy PCR Kit” image=”https:\/\/sola-diagnostics.com\/wp-content\/uploads\/2024\/07\/image-3.png” _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

\n
The WID\u00ae-easy Test is marketed by health institutions, such as diagnostic laboratories, in accordance with the European In Vitro Diagnostics Regulation (IVDR) Article 5, paragraph 5.<\/figcaption><\/figure>\n<\/div>\n

 <\/p>\n

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.0″ _module_preset=”default”][et_pb_column _builder_version=”4.27.0″ _module_preset=”default” type=”4_4″][et_pb_image src=”https:\/\/sola-diagnostics.com\/wp-content\/uploads\/2024\/07\/Screenshot-2024-07-27-at-184714.png” _builder_version=”4.27.0″ _module_preset=”default” title_text=”Screenshot 2024-07-27 at 184714″ url=”https:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045(23)00466-7\/fulltext” url_new_window=”on” hover_enabled=”0″ sticky_enabled=”0″][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

A recent study published in T H E L A N C E T O n c o l o g y demonstrated the ability of the new WID\u00ae-easy Test to render 90% of surgical diagnostic procedures, e.g., hysteroscopy and curettage, unnecessary in women with abnormal bleeding during or after menopause. The test speeds up […]<\/p>\n","protected":false},"author":2,"featured_media":260877,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"1500","footnotes":""},"categories":[14],"tags":[],"class_list":["post-260859","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/sola-diagnostics.com\/en\/wp-json\/wp\/v2\/posts\/260859","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sola-diagnostics.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sola-diagnostics.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sola-diagnostics.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/sola-diagnostics.com\/en\/wp-json\/wp\/v2\/comments?post=260859"}],"version-history":[{"count":0,"href":"https:\/\/sola-diagnostics.com\/en\/wp-json\/wp\/v2\/posts\/260859\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sola-diagnostics.com\/en\/wp-json\/wp\/v2\/media\/260877"}],"wp:attachment":[{"href":"https:\/\/sola-diagnostics.com\/en\/wp-json\/wp\/v2\/media?parent=260859"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sola-diagnostics.com\/en\/wp-json\/wp\/v2\/categories?post=260859"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sola-diagnostics.com\/en\/wp-json\/wp\/v2\/tags?post=260859"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}